Deals
Value Investor Wally Weitz Sells Off Remaining Valeant Stake
- Statement cites drug company's pricing, business practices
- Firm calls investment ``very profitable'' over four years
This article is for subscribers only.
Wally Weitz, a value investor from Warren Buffett’s home town of Omaha, Nebraska, said his firm exited its remaining investment in Valeant Pharmaceuticals International Inc.
“Recent developments about the company’s pharmacy relationships, pricing policies and business practices led us to sell our remaining shares in late October,” Weitz’s firm, Weitz Investment Management, said in a statement posted Monday on its website.